OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-12-31-accounts

Charity Registration No. 1182637 (England and Wales)

Charity Registration No. SC049948 (Scotland) Company Registration No. CE016951 (England and Wales)

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2020

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees David Oxnam (Chair of Board of Trustees) Dr Daniel Saunders (Treasurer) Gayle Routledge Rachel Wilcox David Hobin (Appointed 14 April 2021) Sarah Curtis (Appointed 14 April 2021) Chief Executive Ashley Gamble Charity number 1182637 (England and Wales) SC049948 (Scotland) Company number CE016951 Operating name CCLG Principal address Century House 24 De Montfort Street Leicester LE1 7GB Auditor Newby Castleman LLP West Walk Building 110 Regent Road Leicester LE1 7LT Bankers HSBC Bank Plc 2-6 Gallowtree Gate Leicester LE1 1DA National Westminster Bank Plc 1 Granby Street Leicester LE1 6EJ Scottish Widows Bank Plc PO Box 12757 67 Morrison Street Edinburgh EH3 8YJ CAF Bank Ltd 25 Kings Avenue Kings Hill Kent ME19 4JQ

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

CONTENTS

Page
Trustees' report 1 - 10
Independent auditor's report 11 - 13
Statement of financial activities 14
Balance sheet 15
Statement of cash flows 16
Notes to the financial statements 17 - 33

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 DECEMBER 2020

The trustees of The Children’s Cancer and Leukaemia Group are pleased to present their annual report and financial statements for the year ended 31 December 2020.

The financial statements have been prepared in accordance with the accounting policies set out in the notes to the accounts and comply with the charity’s governing document, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (“FRS 102”), Accounting and Reporting by Charities: the Statement of Recommended Practice for charities applying FRS 102 (2019), the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005, and UK Generally Accepted Accounting Practice.

OBJECTIVES AND ACTIVITIES

The objectives of The Children’s Cancer and Leukaemia Group (CCLG) as defined in the constitution are:

For the public benefit, the relief of sickness and suffering of children, teenagers and young adults with cancer and advancement of education in the field of children, teenagers and young adults with cancer, in particular but not exclusively by:

  1. The relief of sickness and promotion and protection of good health by supporting research into the nature, causes, diagnosis, treatment and social consequences of cancer in children, teenagers and young adults, and to publish the useful results of such research.

  2. The relief of suffering of children, teenagers and young adults with cancer and their families and carers, through the provision of information and support services to them.

  3. The advancement of the education of the public in all areas relating to cancer in children, teenagers and young adults.

  4. The advancement of education and clinical practice by the dissemination of knowledge of the latest research and best practice amongst professionals and practitioners engaged in the treatment, care and support of children, teenagers and young adults with cancer.

The main beneficiaries of the work carried out by the charity are children, teenagers and young adults with cancer and their families in the United Kingdom and elsewhere in the world.

CCLG is the UK and Ireland’s professional association for all those involved in the treatment and care of children with cancer (including leukaemia). Our multidisciplinary and multi-professional membership continues to grow. At the end of 2020, there were in excess of 1000 members. In addition, we host Teenagers and Young Adults with Cancer (TYAC), a multidisciplinary and multi-professional membership association for those involved in the treatment and care of teenagers and young adults with cancer. At the end of 2020, there were more than 400 TYAC members.

Through our membership activities, we provide an active forum for professionals to work together to share best practice and advance education and professional development. Members are able to network with both national and international colleagues for advice and support and receive information and vital updates on specific diseases and treatments. This ensures every child with cancer receives the best possible treatment and care available wherever they live.

The activities of our professional association and membership body include:

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Our members are dedicated to ensuring that children and young people have a greater chance of survival and a better life after treatment.

We support children and young people with cancer and their families in a variety of different ways:

The outstanding progress made in cancer treatment is the result of extensive research studies and clinical trials over the last 40 years which now underpin today's standard treatments. During this time, CCLG has played a key role in the success seen in the world of children's cancer so that now over 80% of children are cured.

But there are still some childhood cancers with a poor outlook, and some treatments can have long-lasting and devastating side effects. Further research is vital to improve survival rates and to find kinder treatments.

We fund and support a variety of research into childhood cancers including:

We measure our success in achieving our objectives in a number of ways:

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

ACHIEVEMENTS AND PERFORMANCE

2020 was our first full year as a charitable incorporated organisation (CIO) following conversion in 2019 after the previous unincorporated charity ended its longstanding hosting agreement with the University of Leicester. Following the transfer, the CIO continues the same activities the unincorporated charity undertook.

Like many charities, the global COVID-19 pandemic had a huge impact on our work during 2020. Some of our usual activities were unable to continue, such as professional education meetings and events. The need to minimise the impact on our finances resulted in using the Government’s Coronavirus Job Retention Scheme to flexibly furlough a number of staff, resulting in a reduced ability to carry out other activities. The impact of restrictions to control the virus had a huge impact on our ability to raise funds, with in-person community events being unable to be held for most of the year and the cancellation of major mass participation events such as the London Marathon.

Despite the challenges of 2020, CCLG continues to go from strength to strength. We continued to work towards the four main goals set out in our strategic plan launched in January 2018, and the goals of the TYAC strategic plan launched in 2019.

Providing leadership and expertise for the treatment and care of children and young people with cancer

As the UK and Ireland’s professional association for those working in the field of paediatric oncology and haematology, CCLG is a leading voice for children’s cancer, liaising with community groups, the government and the NHS to influence policies. We use our expertise to improve treatment and care and meet the needs of patients and families. In 2020:

Improving diagnosis times by increasing awareness

The significance of a delayed diagnosis presents a challenge for primary health care professionals, who are required to triage symptoms that may point to a cancer diagnosis from those which are not and make appropriate onward referrals. Many symptoms associated with cancer are non-specific and are seen every day in general practice, whilst a cancer diagnosis is seen infrequently. Delays in the diagnostic pathway may well lead to more advanced disease at presentation, with subsequent greater risk of death, greater morbidity, and inevitably, distrust of the medical system. There is evidence that tumours presenting in childhood in the

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

UK are larger, at a more advanced stage and require more therapy than those presenting in other parts of Europe. We work to improve diagnosis times for children and young people with cancer. In 2020:

Strengthening our expert information portfolio to support more families of a child with cancer

Looking after a child with cancer can be a scary and lonely experience for families. Our goal is to deliver the right information at the right time and make a positive difference to their daily lives.

We continue to be the leading provider of expert-written, award-winning and quality-assured information about all aspects of childhood cancer, from diagnosis to life when treatment has finished. In 2020:

Supporting and funding world-class research

Our aim is to both support and fund world-class research, deepen understanding and foster collaborations across the childhood cancer community. One of our most important areas of work is to offer opportunities for our members to develop scientific networks and belong to a wider research community dedicated to childhood cancer. Our Research Strategy outlines our exciting plans to fund and support innovative world-class research into childhood cancer and recognises the importance of collaboration, both nationally and internationally, to achieve improvements.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Teenagers and Young Adults with Cancer (TYAC)

Teenagers and Young Adults with Cancer (TYAC) is the professional association for those working in teenage and young adult (TYA) oncology. TYAC merged with CCLG in 2018, and in 2019 we launched a new strategy for the work of TYAC, setting out how we would continue to drive improvements in TYA cancer care, and support the development of professionals working in the field. During the year, the COVID-19 pandemic disrupted the activities of TYAC more than the rest of CCLG’s work, primarily due to the disruption to TYA services in the NHS and the impact of this on our members. In 2020, we commissioned a new TYAC website to better support our ambitions to support both the professional members, and TYA with cancer, as well as raising funds under the TYAC brand. We developed a research strategy for TYAC, which will begin to fund and support research into TYA cancer, supported by increased fundraising under the TYAC brand, in 2021.

Fundraising

All of our work is dependent on the generosity of our supporters. A programme of fundraising underpins our ability to fund research, support patients and families, and improve treatment and care for children and young people with cancer. In 2020:

COVID-19

In response to the COVID-19 pandemic, we undertook a number of activities during the year to support the families of children and young people with cancer during the unprecedented circumstances:

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Fundraising policy

We are reliant on donations to fund our vital work. Without the generosity of the public, we would not be able to continue providing support to children and young people diagnosed with cancer, and their families, nor fund research into childhood cancer.

We believe that it is essential that we are clear and open about how we raise our funds and about the range of ways people can get involved and support our work.

People raise money for us in many different ways, including through taking part in sporting events, organising events in their local community, or fundraising at their place of work. We also provide opportunities for people to fundraise through providing access to places in key events, such as the London Marathon, and through providing fundraising materials.

Our supporters can sign up to make regular donations, or to play our lottery which we launched in 2018.

We work with a number of corporate partners, and have received support from charitable trusts and foundations, and through grants from other charities. We do not carry out door-to-door fundraising, nor do we use street fundraising to sign up supporters to regular donations. Currently, none of our fundraising activities are conducted on our behalf by professional fundraising agencies.

CCLG is registered with the Fundraising Regulator. We are committed to adhering to the Code of Fundraising Practice. During the year, we received no complaints about our fundraising activities. Regular updates are provided to our board of trustees to ensure that they have a good oversight of our activities.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

FINANCIAL REVIEW

Transactions for the year ended 31 December 2020 fall into roughly the same categories as in previous years. Income generally consists of donations and fundraising income, subscriptions (comprising individual membership subscriptions and hospital subscriptions for health information), registration fees for meetings and events, funding from partner charities such as The Little Princess Trust to support research projects awarded through strategic partnerships, legacy income, and this year income from the Coronavirus Job Retention Scheme. We are grateful to CLIC Sargent and Teenage Cancer Trust for their continued support of TYAC activity.

The major items of expenditure for CCLG remain staff salaries, professional meeting and event costs, the costs associated with the production of health information, and the awarding of research grants.

Staffing costs represent a significant financial commitment, but our small, expert staff team is also responsible for the achievement of the majority of our charitable objectives. Staffing levels are kept under review, with the small, efficient team carrying out and coordinating the considerable activities of the charity.

Our overall income fell by £2,381,008 during 2020, compared with the year ending December 2019. Primarily this was due to the impact of the COVID-19 pandemic, which saw a fall in the number of rounds of grant funding offered by partner charities such as the Little Princess Trust, a reduction in fundraising income, and a fall in income from meetings and events which were unable to take place.

CCLG has a number of restricted funds. Internal records are kept according to requirements for restriction, i.e. tumour specific donations or donations for a specific piece of work. The restricted funds are ring-fenced to support specific projects or areas of activity and cannot be used to support the general running costs of the organisation.

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. Expenditure decreased in 2020 by £2,283,561 compared to 2019. The primary reason for this increase was the awarding of fewer research grants, and not holding meetings and events due to the COVID-19 pandemic.

Early in the year, we re-forecasted our budget based on assumptions about the pandemic and its impact. At this point it looked likely we would need to call on our reserves during the year to ensure the charity was able to meet its commitments. During the year, thanks to implementing cost-saving measures, a natural reduction in some expenditure (e.g. staff and member travel) as a result of pandemic restrictions, use of the coronavirus job retention scheme, and unexpected significant income from legacies, we ended the year with a surplus of £173,050 in unrestricted income and expenditure, which covered the majority of our core costs. Overall, we ended the year on a deficit of £157,367 and did not need to call on our free reserves, with the deficit in restricted income and planned expenditure being £330,417. However, our overall income was significantly lower than 2019.

Reserves Policy

The trustees continue to consider the appropriate balance of financial stability and investment in charitable activity. The COVID-19 pandemic has highlighted the importance of an appropriate reserves policy. Given the ongoing uncertainty around the pandemic and the length of time likely until we recover fully, it is important we continue to hold a level of reserves which can sustain our activity until we have a better picture of what postpandemic fundraising might look like, both in the short- and medium-term. We have plans in place to ensure CCLG is ‘fit for the future’ and our reserves policy will ensure we are able to meet those plans.

At the end of the year, we have reviewed our reserves policy for CCLG and aim to hold a target level of free reserves (unrestricted funds less tangible fixed assets) of £400,000, which the trustees consider to be approximately six months of core expenditure, including staff salaries, accommodation costs and general running costs.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Total reserves at 31 December 2020 were £1,653,937 of which £975,322 are restricted and £678,615 are unrestricted. As at 31 December 2020 the charity’s free reserves totalled £637,092, which is in excess of the reserves policy due to the notification of legacies at the year-end. The trustees consider that this ensures that CCLG is ‘fit for the future’.

- The financial impact of the COVID 19 pandemic

As highlighted throughout this report, the COVID-19 pandemic in 2020 has had a huge impact on CCLG, both in our operations and our income generation. With many major fundraising events – notably the London Marathon – cancelled, as well as the varying lockdowns and other restrictions during the year preventing many types of fundraising events from being organised, our fundraising income was significantly reduced during the year. The inability to hold ‘in-person’ meetings and events meant that the majority of our education and scientific meetings and conferences – another key source of income – were cancelled, although this was mitigated to some extent by the corresponding decrease in expenditure on the cost of holding such events.

The Trustees and the Chief Executive have considered various scenarios for our finances during the coming year, which are unlikely to recover fully to pre-pandemic levels until at least 2022. We have taken the opportunity to review our activities and strategy, and ensure we have the right team in place to deliver on the charity’s priorities for the coming year, including in fundraising. This includes a restructuring of the staff team in early 2021, which may sadly include some redundancies, but will also include the creation of some new staff posts.

As well as focusing on mitigating the impact on the charity as much as possible, to secure the future of our work, The Trustees and the Chief Executive have liaised closely during this year to ensure the wellbeing of staff. We have used the government’s Coronavirus Job Retention Scheme (“furlough scheme”), taking the difficult decision to furlough a number of our staff team, and then bring them back on reduced hours under the ‘flexible furlough’ scheme from July, to support the costs of employing staff during the crisis. This necessitated focusing our work on the most important projects. Supporting our staff throughout this period has been a key priority for the Trustees and Senior Leadership Team. Our staff team is at the heart of what we do and are passionate about the impact CCLG has on children with cancer and their families. We recognise that our committed staff team also have lives outside of their work for CCLG which will have also been affected. The Trustees and Senior Leadership Team are extremely grateful for the dedication of the team, and how they have adapted to the current situation to ensure our vital work continues. We asked all staff to work from home, where possible, from early March, and offered flexible work patterns to suit the new circumstances of our team members. We offered regular online ‘social catch-ups’ for team members as well as ensuring regular updates were provided directly in team meetings, and through our internal social media platform.

Investment policy

The Trustees previously reviewed our plans for investments to consider the most appropriate way of managing these, balancing cashflow, risk and reward. Given the uncertainty of the financial impact of the UK leaving the European Union, and the COVID-19 pandemic, no further action has been taken on investments. Management accounts are produced for the trustees, and a cashflow forecast considerably facilitates management and prediction of charity income.

Risk Management

CCLG is also aware of the requirement to carry out a risk review of its activities. The trustees reviewed the risks the charity faces during the year. A Risk Register is in operation, documenting the systems in place to mitigate those risks, and is kept under review by the trustees.

FUTURE ACTIVITIES

All future activities planned are designed to ensure that CCLG continues to fulfil its objectives for children and young people with cancer, and their families, as the ultimate beneficiaries.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

As the membership of CCLG continues to grow, so does the activity our members are involved in. Our specialist network groups continue to be increasingly active, supporting our activities and providing specialist advice to commissioners of healthcare services and others. The CCLG Executive continues to consider was that CCLG can advance education and professional development, and share and guide best practice.

The CCLG executive is a committee comprised of elected members of the CCLG professional body, along with the CEO, who have delegated authority from the Trustees for deciding and implementing the strategy of the organisation as it relates to the clinical, research and professional elements of our work.

At the end of 2020, as an AMRC member we participated in their 5-yearly peer review audit, which gave us the opportunity to review our research strategy and associated processes. We concluded that our current research strategy remains appropriate and plan to launch a new research strategy once the ongoing Children’s Cancer Priority Setting Partnership has concluded and published the top ten research priorities in this field.

We plan to continue to develop our range of patient/parent information products in response to demand and specific needs identified by both end-users and professionals. In 2021, we will launch an updated and revised version of our Parents’ Guide, our key publication which is given to all families upon diagnosis.

We also aim to continue raising awareness of CCLG and its activities, with a view to continuing to increase the income and resources available to us to meet our objectives.

In January 2021, the Trustees and Chief Executive began reviewing the staffing structure of the Charity, recognising the likelihood of reduced financial resources in the short to medium term as a result of the COVID19 pandemic, and to ensure that the right staffing is in place to deliver on our strategic plan.

STRUCTURE, GOVERNANCE AND MANAGEMENT

The Children’s Cancer and Leukaemia Group (CCLG) was established in 1977 and became a registered charity (number 286669) in 1983. In 2019, a new CIO (registration number 1182637) was formed, with the activities, assets and liabilities of the previous charity transferred to the CIO. The charity’s governing instrument is the Constitution and the CIO was first registered in February 2019.

The board of trustees is independent of the CCLG membership. The board of trustees is responsible for managing the charity finances in support of the objectives defined by the CCLG Executive. There are a minimum of two and a maximum of eight trustees. One of the trustees will be the CCLG Treasurer, an elected member of the CCLG Executive, providing a link between these two groups.

If a vacancy arises, the trustees may appoint any eligible person as a trustee. In selecting individuals for appointment as trustees, the trustees will consider the skills, knowledge and experience needed for the effective running of the charity.

Upon appointment, trustees are provided with an induction to the charity. This consists of a briefing paper, as well as meetings with the Chair, CEO, and others as deemed appropriate. Regard is given to the training and development needs of any trustees that may arise.

The board of trustees meets quarterly and is supported by key management personnel. Four meetings were held in 2020.

The trustees come from a range of professional backgrounds, and bring new skills and highly relevant experience.

Trustees serving during the year were: David Oxnam Dr Daniel Saunders Gayle Routledge Rachel Wilcox

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

The Chief Executive is responsible for the day-to-day operation of the charity on behalf of the trustees. The remuneration of key management is reviewed annually by the board and is set against established pay scales, benchmarked in comparison with similar sized entities including both charities and medical professional associations. The trustees give their time freely and no remuneration was paid in the year. Details of trustee expenses are disclosed in note 12 to the accounts.

Key Management Personnel during the year were: Ashley Gamble (Chief Executive) Gill Smitherman (Head of Fundraising) Claire Shinfield (Head of Engagement)

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

The trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England & Wales and Scotland requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005, the Charities (Accounts and Reports) Regulations 2008, the Charities Accounts (Scotland) Regulations 2006 (as amended) and the provisions of the charity’s constitution. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the charity and financial information included on the charity’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

David Oxnam

Chair of the board of trustees

Dated: 12 July 2021

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

INDEPENDENT AUDITOR'S REPORT

TO THE TRUSTEES OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

Opinion

We have audited the financial statements of The Children's Cancer and Leukaemia Group (the ‘charity’) for the year ended 31 December 2020 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and the notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the trustees' report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the trustees' report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 and the Charities Accounts (Scotland) Regulations 2006 require us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees' responsibilities statement set out on 10, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and report in accordance with regulations made under these acts.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Extent to which the audit was considered capable of detecting irregularities

We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. However, responsibility for the prevention and detection of fraud ultimately rests with both those charged with governance and management of the charity.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and noncompliance with laws and regulations, our procedures included the following:

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

Audit response to risks of irregularities identified

Our procedures to respond to risks identified included the following:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008, and Regulation 10 of the Charities Accounts (Scotland) Regulations 2006. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Newby Castleman LLP 2 August 2021 Chartered Accountants Statutory Auditor West Walk Building 110 Regent Road Leicester LE1 7LT

Newby Castleman LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

STATEMENT OF FINANCIAL ACTIVITIES

FOR THE YEAR ENDED 31 DECEMBER 2020

Unrestricted Restricted Total Total
funds funds
2020 2020 2020 2019
Notes £ £ £ £
Income from:
Donations and legacies 3 797,572 504,215 1,301,787 1,131,259
Charitable activities 4 284,190 2,302,758 2,586,948 5,131,664
Investments 5 2,021 - 2,021 8,841
Total 1,083,783 2,806,973 3,890,756 6,271,764
Expenditure on:
Raising funds 6 207,508 - 207,508 253,005
Charitable activities 7 703,225 3,065,633 3,768,858 6,078,679
Other 11 - 71,757 71,757 -
Total 910,733 3,137,390 4,048,123 6,331,684
Net income/(expenditure) for the year/
Net movement in funds 173,050 (330,417) (157,367) (59,920)
Reconciliation of funds
Total funds brought forward 505,565 1,305,739 1,811,304 1,871,224
Total funds carried forward 678,615 975,322 1,653,937 1,811,304

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

BALANCE SHEET

AS AT 31 DECEMBER 2020

2020 2020 2019 2019
Notes £ £ £ £
Fixed assets
Tangible assets 14 41,523 51,150
Current assets
Stocks 15 38,697 30,514
Debtors 16 3,105,582 2,781,938
Cash at bank and in hand 3,926,525 2,776,343
7,070,804 5,588,795
Liabilities
Creditors: amounts falling due within one
year 17 (3,053,855) (1,743,072)
Net current assets 4,016,949 3,845,723
Total assets less current liabilities 4,058,472 3,896,873
Creditors: amounts falling due after
more than one year 18 (2,404,535) (2,085,569)
Total net assets 1,653,937 1,811,304
The funds of the charity
Restricted funds 21 975,322 1,305,739
Unrestricted funds 22 678,615 505,565
Total charity funds 1,653,937 1,811,304

The financial statements were approved and authorised for issue by the board of trustees on 12 July 2021 and are signed on its behalf by:

David Oxnam (Chair of Board of Trustees)

Trustee

The notes on pages 17 - 33 form part of these financial statements.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2020

2020 2020 2019 2019
Notes £ £ £ £
Cash flows from operating activities
Cash generated from operations 27 1,148,161 278,848
Investing activities
Purchase of tangible fixed assets - (53,151)
Investment income received 2,021 8,841
Net cash generated from/(used in)
investing activities 2,021 (44,310)
Net cash used in financing activities - -
Net increase in cash and cash equivalents 1,150,182 234,538
Cash and cash equivalents at beginning of year 2,776,343 2,541,805
Cash and cash equivalents at end of year 3,926,525 2,776,343

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

1 Accounting policies

Charity information

The Children's Cancer and Leukaemia Group is governed by its Constitution.

1.1 Basis of preparation

The charity is a public benefit entity as defined by FRS102. These financial statements have been prepared in accordance with: The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (“FRS 102”), Accounting and Reporting by Charities: the Statement of Recommended Practice for charities applying FRS 102 (2019), the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005, and UK Generally Accepted Accounting Practice.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below. These policies have been consistently applied.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives unless the funds have been designated for other purposes.

Designated funds are unrestricted funds of the charity that the trustees have decided at their discretion to set aside for specific purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

1.4 Income recognition

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

For legacies, income is recognised and included in the financial statements when all of the following criteria are met:

Where legacies have been notified to the charity but the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

1 Accounting policies

(Continued)

Donated facilities and donated services are recognised as income at their fair value when their economic benefit is probable, it can be measured reliably and the charity has control over the item. Fair value is determined on the basis of the value of the gift to the charity. For example the amount the charity would be willing to pay in the open market for such facilities and services. A corresponding amount is recognised in expenditure.

Government grants are recognised at fair value when the charity has entitlement after any performance conditions have been met, it is probable that the income will be received and the amount can be measured with reliability. If entitlement is not met, then the amounts are deferred.

Income from charitable activities includes income received from grants, registration fees for meetings, member subscriptions and publication payments. Such income is recognised at fair value when the charity has entitlement after any performance conditions have been met, it is probable that the income will be received and the amount can be measured with reliability. If entitlement is not met, then the amounts are deferred.

Investment income is earned through holding assets for investment purposes. It comprises bank interest and is recognised on an accruals basis.

1.5 Expenditure recognition

All expenditure, including the awarding of grants, is accounted for on an accruals basis and has been classified under headings that aggregate all costs relating to the category. Expenditure is recognised when there is a legal or constructive obligation to make payments to third parties, it is probable that settlement will be required and the amount of the obligation can be measured reliably. It is recognised under the following headings:

1.6 Support costs

Support costs are those that assist the work of the charity but do not directly represent charitable activities and costs of raising funds and include office costs, governance costs and administrative payroll costs. They are incurred directly in support of expenditure in line with the objectives of the charity. Support costs are allocated to costs of raising funds and expenditure on charitable activities on a basis consistent with use of the resources.

The analysis of these costs is included in note 10.

1.7 Tangible fixed assets

Tangible fixed assets are measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Computer equipment, furniture and fixtures 5-10 years

1.8 Stocks

Stocks include merchandise stock and educational literature. Stocks that are held for resale are stated at the lower of cost and estimated selling price. Stocks held for distribution as part of the charity’s activities are valued at their service potential, which the charity considers to be the cost of the materials.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

1 Accounting policies

(Continued)

1.9 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less.

1.10 Financial instruments

Financial instruments are recognised in the charity’s balance sheet when the charity becomes party to the contractual provisions of the instrument.

Debtors and creditors with no stated interest rate and receivable or payable within one year are measured at transaction price. Any losses arising from impairment are recognised in the Statement of Financial Activities.

1.11 Employee benefits

When employees have rendered service to the charity, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The trustees do not consider there to be any key sources of estimates or uncertainty that have a significant effect on the amounts recognised in the financial statements.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

3 Income from donations and legacies

Unrestricted Restricted Total Unrestricted Restricted Total
funds funds funds funds
2020 2020 2020 2019 2019 2019
£ £ £ £ £ £
Donations 372,572 432,458 805,030 445,686 545,144 990,830
Legacies 425,000 - 425,000 117,452 - 117,452
Government grants - 71,757 71,757 - - -
Donated goods and
services - - - 22,977 - 22,977
797,572 504,215 1,301,787 586,115 545,144 1,131,259
**Unrestricted ** **Unrestricted ** **Unrestricted ** Restricted Restricted Total Total Unrestricted Restricted Total
funds funds funds funds
2020 2020 2020 2019 2019 2019
£ £ £ £ £ £
Registration fees for meetings 64,709 7,119 71,828 152,486 13,723 166,209
Member subscriptions and
publication payments 159,481 - 159,481 149,190 - 149,190
Grant income for research
and operations 60,000 2,295,639 2,355,639 73,000 4,743,265 4,816,265
284,190 2,302,758 2,586,948 374,676 4,756,988 5,131,664
Income from investments
Unrestricted Restricted Total Unrestricted
Restricted		 Total
funds funds funds funds
2020 2020 2020 2019 2019 2019
£ £ £ £ £ £
Interest 2,021 - 2,021 8,841 - 8,841

5 Income from investments

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

6 Expenditure on raising funds

Unrestricted Unrestricted Restricted Restricted Restricted Total Unrestricted Unrestricted Unrestricted Restricted Total
funds funds funds funds
2020 2020 2020 2019 2019 2019
£ £ £ £ £ £
Costs of raising funds
Virgin Money Giving
deductions 11,703 - 11,703 11,195 - 11,195
Website 3,792 - 3,792 2,588 - 2,588
Fundraising, marketing
and publicity costs 59,035 - 59,035 112,868 - 112,868
Support costs (note 10) 132,978 - 132,978 126,354 - 126,354
207,508 - 207,508 253,005 - 253,005
Expenditure on charitable activities
Activities Grant Support Total Total
undertaken funding Costs 2020 2019
directly
Note 8 Note 9 Note 10
£ £ £ £ £
Support for research 36,541 3,025,744 137,930 3,200,215 5,399,284
Information for patients and families 36,853 - 205,874 242,727 240,810
Improving treatment and care 108,683 - 217,233 325,916 438,585
182,077 3,025,744 561,037 3,768,858 6,078,679
Unrestricted funds 703,225 836,231
Restricted funds 3,065,633 5,242,448
3,768,858 6,078,679

7 Expenditure on charitable activities

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

8 Expenditure on activities undertaken directly

Support for Support for Support for
Information
Information
Improving
Improving		 Total Total
research for patients treatment 2020 2019
and families and care
£ £ £ £ £
Staff costs 17,020 - - 17,020 3,466
Other tumour specific expenditure 15,729 - - 15,729 59,795
Contact magazine expenses - 18,680 - 18,680 9,760
Other publication expenses - 12,484 - 12,484 35,587
Website 3,792 5,689 5,688 15,169 10,124
Cost of meetings - - 81,017 81,017 193,660
Travel expenses - - 4,870 4,870 17,887
Other expenses - - 17,108 17,108 27,311
36,541 36,853 108,683 182,077 357,590
9 Expenditure on grant funding
Support for
Information		 Improving Total Total
research for patients treatment 2020 2019
and families and care
£ £ £ £ £
Grants to institutions:
University of Birmingham 166,952 - - 166,952 481,477
University of Surrey 9,844 - - 9,844 50,286
Newcastle University 74,582 - - 74,582 500,944
UCL Institute of Child Health 424,623 - - 424,623 562,149
University of Sheffield 206,625 - - 206,625 72,656
University of Nottingham 255,841 - - 255,841 1,302,800
University of Ulster 216,108 - - 216,108 74,933
University of Bristol - - - - 198,557
Queen's University Belfast - - - - 74,997
Great Ormond Street 14,954 - - 14,954 170,366
University of Southampton 245,079 - - 245,079 111,236
University Hospital of Wales - - - - 71,490
Genome Research Limited - - - - 950,820
University of Glasgow 439,610 - - 439,610 98,793
University of York 105,027 - - 105,027 -
University of Cambridge 136,392 - - 136,392 -
Institute of Cancer Research 299,236 - - 299,236 275,103
University of Leeds 110,775 - - 110,775 205,715
University of Manchester - - - - 3,000
University of Portsmouth 100,901 - - 100,901 -
University of Oxford 219,195 - - 219,195 -
3,025,744 - - 3,025,744 5,205,322

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

9 Expenditure on grant funding

(Continued)

The charity awards grants for specific research projects to various institutions, as part of their charitable activities.

10 Expenditure on support costs

Expenditure on support costs
Basis of allocation 2020 2019
£ £
Staff costs *1 505,149 456,598
Depreciation & loss on disposal *1 9,627 39,760
Occupancy expenses *1 131,841 97,589
Postage *1 12,275 20,265
Staff training *1 6,000 6,985
Professional fees 1 / 2 29,123 20,924
694,015 642,121
Analysed between
Trading 132,978 126,354
Charitable activities 561,037 515,767
694,015 642,121

*1 Support costs, excluding governance costs, have been allocated as follows: Cost of raising funds 20% (2019 - 20%) Charitable activities Support for research 20% (2019 - 20%) Information for patients and families 30% (2019 - 30%) Improving treatment and care 30% (2019 - 30%)

*2 Professional fees include governance costs of £29,123 (2019 - £10,352). Governance costs have been allocated as follows: Charitable activities Support for research 17% (2019 - 17%) Information for patients and families 22% (2019 - 22%) Improving treatment and care 61% (2019 - 61%)

The amount charged to the SOFA in respect of auditor's remuneration was:

11 Other expenditure

Unrestricted Restricted Total Unrestricted Restricted Total
funds funds funds funds
2020 2020 2020 2019 2019 2019
£ £ £ £ £ £
Wages - 71,757 71,757 - - -

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

12 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits during the year. 1 of the trustees was reimbursed for travel expenses amounting to £63 (2019 - 3 trustees were reimbursed for travel expenses of £1,757).

13 Employees

The average monthly number of employees during the year was:

2020 2019
Number Number
Total 18 15
Employment costs 2020 2019
£ £
Wages and salaries 499,229 176,828
Social security costs 45,200 16,621
Other pension costs 49,497 17,613
Recharges from the University of Leicester - 249,002
593,926 460,064

Staff working for the charity were employed directly by the University of Leicester until 1 August 2019. Their gross salary and pension costs were recharged to the charity.

The number of employees whose annual remuneration was £60,000 or more were:

2020 2019
Number Number
£60,001 - £70,000 - 1
£80,001 - £90,000 1 -

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

14 Tangible fixed assets

14 Tangible fixed assets
Computer Total
equipment,
furniture
and fixtures
£ £
Cost
At 1 January 2020 63,202 63,202
At 31 December 2020 63,202 63,202
Depreciation and impairment
At 1 January 2020 12,052 12,052
Depreciation charged in the year 9,627 9,627
At 31 December 2020 21,679 21,679
Carrying amount
At 31 December 2020 41,523 41,523
At 31 December 2019 51,150 51,150
15 Stocks
2020 2019
£ £
Merchandise stock 23,564 10,659
Educational literature 15,133 19,855
38,697 30,514

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

16 Debtors
2020 2019
Amounts falling due within one year: £ £
Trade debtors 10,152 81,352
Grant debtors 1,661,876 1,045,933
Rent deposit 16,200 16,200
Prepayments and accrued income 140,633 200,511
Accrued legacy income 445,000 65,000
2,273,861 1,408,996
2020 2019
Amounts falling due after more than one year: £ £
Grant debtors 831,721 1,372,942
Total debtors 3,105,582 2,781,938
17 Creditors: amounts falling due within one year
2020 2019
Notes £ £
Deferred income 19 - 19,095
Trade creditors 20,902 23,115
Grant creditors 2,987,921 1,681,177
Accruals 45,032 19,685
3,053,855 1,743,072
18 Creditors: amounts falling due after more than one year
2020 2019
£ £
Grant creditors 2,404,535 2,085,569

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

19 Deferred income

2020 2019
£ £
Total deferred income at 1 January 2020 19,095 7,410
Amounts released into incoming resources (19,095) (7,410)
Amounts deferred in year - 19,095
Total deferred income at 31 December 2020 - 19,095

Deferred income comprises advanced registration fees for meetings.

20 Retirement benefit schemes

Defined contribution schemes

The charity operates a defined contribution pension scheme for all qualifying employees.

The amount recognised in unrestricted expenditure was £49,497 (2019 - £24,231).

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

21 Restricted funds

The income funds of the charity include restricted funds which comprise the following unexpended balances of donations and grants held on trust for specific purposes:

Movement in funds Movement in funds
Balance at Income Expenditure Balance at
1 January 31 December
2020 2020
£ £ £ £
Tumour specific funds 930,227 425,593 (611,172) 744,648
CCLG Prize 304 - (250) 54
General research fund 2,982 6,387 (5,429) 3,940
Adam Hay fund 11,861 120 (999) 10,982
CCLG Senior Members Group 7 - - 7
PODC 3,317 1,462 (1,441) 3,338
POTG 2,139 - - 2,139
The Little Princess Trust fund 6,200 2,248,667 (2,248,667) 6,200
Treatment Guidelines fund 18,661 - (226) 18,435
TYAC Lisa Thaxter 45,412 - - 45,412
Child Cancer Smart 174,944 - (101,444) 73,500
PORT 200 200 - 400
CCLG Research Network Partner Charity 72,656 46,972 (83,300) 36,328
CYP Coalition Activity 9,034 - (9,034) -
Neuroblastoma Nursing Group 6,000 4,500 - 10,500
Childhood Cancer Priority Setting Partnership 21,580 - (3,671) 17,909
PODC - Iraq Fund 215 1,315 - 1,530
Coronavirus Job Retention Scheme - 71,757 (71,757) -
1,305,739 2,806,973 (3,137,390) 975,322

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

21 Restricted funds (Continued)
Movement in funds
Balance at Income Expenditure Balance at
1 January 31 December
2019 2019
£ £ £ £
Tumour specific funds 985,978 543,783 (599,534) 930,227
CCLG Prize 354 - (50) 304
General research fund 2,122 860 - 2,982
Adam Hay fund 11,776 220 (135) 11,861
CCLG Senior Members Group 7 - - 7
PODC 3,562 1,851 (2,096) 3,317
POTG 6,231 6,679 (10,771) 2,139
The Little Princess Trust fund 6,165 4,507,368 (4,507,333) 6,200
Treatment Guidelines fund 18,948 - (287) 18,661
TYAC Lisa Thaxter 45,712 - (300) 45,412
Child Cancer Smart 165,000 20,000 (10,056) 174,944
PORT 200 - - 200
CCLG Research Network Partner Charity - 152,656 (80,000) 72,656
CYP Coalition Activity - 12,500 (3,466) 9,034
Neuroblastoma Nursing Group - 6,000 - 6,000
Childhood Cancer Priority Setting Partnership - 50,000 (28,420) 21,580
PODC - Iraq Fund - 215 - 215
1,246,055 5,302,132 (5,242,448) 1,305,739

Tumour specific funds

Represents income received from donors with a specific request that the funds are used in support of grants for a particular tumour type.

CCLG Prize

Represents income received from donors to fund the CCLG Prize.

General research fund

Represents income received from donors with a specific request that the funds are used for research purposes.

Adam Hay fund

This fund has been established to continue work done by the Adam Hat's charity (which merged with CCLG in 2011) in neuroblastoma research and psychological support for children and families.

CCLG Senior Members Group

Represents income received from the Senior Members’ Group to be used for their activities.

PODC

Represents income received from donors to be used for the Paediatric Oncology in Developing Countries (PODC).

POTG

Represents income received from donors to be used for the Paediatric Oncology Trainees' Group (POTG).

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

21 Restricted funds

(Continued)

The Little Princess Trust fund

Represents income received from The Little Princess Trust to fund future instalments of research grants awarded.

Treatment Guidelines fund

Represents a grant received for the development of rare endocrine tumour guidelines.

TYAC Lisa Thaxter

Represents income received for providing and supporting education and training to professionals working in the field of teenage and young adult cancer. This was previously a restricted fund in TYAC and has transferred to CCLG as part of the closure of TYAC, with the same restrictions maintained.

Child Cancer Smart

Represents income received for a research programme, guideline development and awareness raising focusing on earlier diagnosis of childhood cancer.

PORT

Represents income received for the Paediatric Oncology Reference Team, a group of parents of children with cancer who review clinical trial and other research information to ensure it is appropriate for children with cancer and their families.

CCLG Research Network Partner Charity

Represents income research from other charities to fund research projects.

CYP Coalition Activity

Represents income received from charity members of the Children and Young People's Cancer Coalition for the costs of providing the Coalition secretariat.

Neuroblastoma Nursing Group

Represents income received to support the costs of running the national neuroblastoma nursing group, a group of CCLG member nurses with a special interest in neuroblastoma.

Childhood Cancer Priority Setting Partnership

Represents grant income received to support the James Lind Alliance supported Childhood Cancer Priority Setting Partnership being led by CCLG.

PODC - Iraq Fund

Represents donations received to specifically support work to improve the treatment and care of children with cancer in Iraq.

Coronavirus Job Retention Scheme

Represents amounts received from the Government to cover staff costs during the Covid-19 pandemic.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

22 Unrestricted funds

The unrestricted funds of the charity include general funds and designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

Movement in funds Movement in funds Movement in funds Movement in funds
Balance at **Income ** Expenditure Transfers Balance at
1 January 31 December
2020 2020
£ £ £ £ £
General funds 505,565 1,083,783 (910,733) - 678,615
Movement in funds
Balance at **Income ** Expenditure Transfers Balance at
1 January 31 December
2019 2019
£ £ £ £ £
General funds 622,964 969,632 (1,089,236) 2,205 505,565
Treatment Guidelines fund 2,205 - - (2,205) -
625,169 969,632 (1,089,236) - 505,565

Treatment Guidelines fund

Represents a sum set aside by the trustees for the development of rare endocrine tumour guidelines.

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2020

23 Analysis of net assets between funds

Analysis of net assets between funds
Unrestricted
Restricted		 Total
Funds Funds
2020 2020 2020
£ £ £
Fund balances at 31 December 2020 are represented by:
Tangible assets 41,523 - 41,523
Current assets/(liabilities) 637,092 3,379,857 4,016,949
Long term liabilities - (2,404,535)
(2,404,535)
678,615 975,322 1,653,937
Unrestricted
Restricted		 Total
Funds Funds
2019 2019 2019
£ £ £
Fund balances at 31 December 2019 are represented by:
Tangible assets 51,150 - 51,150
Current assets/(liabilities) 454,415 3,391,308 3,845,723
Long term liabilities - (2,085,569)
(2,085,569)
505,565 1,305,739 1,811,304

24 Events after the reporting date

Legacy income

Legacy income amounting to £172,000 was notified and received after 31 December 2020 and has not been recognised in these accounts.

COVID-19

The ongoing COVID-19 pandemic resulted in another national lockdown in January 2021. Therefore income from fundraising events, meetings and conferences has remained lower than pre-pandemic levels. The charity has continued to use the coronavirus job retention scheme during the period. More detail is included in the trustees report on how COVID-19 has impacted the charity and the measures the trustees have taken to try and mitigate its impact.

25 Operating lease commitments

At the reporting end date the charity had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2020 2019
£ £
Within one year 27,530 27,530
Between two and five years 75,707 103,237
103,237 130,767

THE CHILDREN'S CANCER AND LEUKAEMIA GROUP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

25 Operating lease commitments

(Continued)

Amounts recognised in the SOFA as an expense during the period in respect of operating lease arrangements are £27,530 (2019 - £6,882).

26 Related party transactions

Remuneration of key management personnel

The remuneration of key management personnel, is as follows.

2020 2019
£ £
Aggregate compensation 161,873 99,697

There have been no other related party transactions in the reporting period that require disclosure in the financial statements, other than those noted in note 12 to the financial statements.

27 Cash generated from operations 2020 2019
£ £
Deficit for the year (157,367) (59,920)
Adjustments for:
Investment income recognised in statement of financial activities (2,021) (8,841)
(Gain)/loss on disposal of tangible fixed assets - 30,133
Depreciation and impairment of tangible fixed assets 9,627 9,627
Movements in working capital:
(Increase)/decrease in stocks (8,183) 24,915
(Increase) in debtors (323,644) (2,671,531)
Increase in creditors 1,648,844 2,942,780
(Decrease)/increase in deferred income (19,095) 11,685
Cash generated from operations 1,148,161 278,848

28 Analysis of changes in net funds

During the year the charity had no borrowings or obligations under finance leases. The changes in net funds of the charity therefore solely comprise of cash and cash equivalents.